Ace Therapeutics is an expert in the field of liver disease drug development. We aim to provide you with the highest quality drug development services for liver disease.
Liver cell death maintains a dynamic balance in the liver. But if there are factors, such as disease, that disrupt this balance, it can promote the development of disease. Cell death is the pathogenic basis of almost all liver diseases, therefore, targeting cell death to develop drugs for liver diseases is a very effective direction for drug development. Based on our advanced technology platform and rich practical experience, we aim to provide you with professional drug development services to escort your research.
What Can We Do?
There are various types of cell death and various pathological processes that exist in liver disease. After years of practical experience, our scientists have organically combined the two and established a comprehensive service system for developing liver disease drugs targeting cell death.
- Screening for Regulators Targeting Cell Death
Screening candidate regulators against cell death is the first step in drug development. We provide quality research services from screening techniques and screening protocols to the analysis of final results to ensure the scientific validity of your study.
- Based on our large compound library, we can easily achieve high throughput screening of different compounds.
- We offer different assays for different cell death types, such as morphological assays, DNA monitoring analysis, flow cytometry analysis, biomarker assays, and others.
- We can provide in vitro models of different liver diseases for the preliminary activity evaluation of candidate regulators.
- Development of Regulators Targeting Cell Death for Liver Disease
Given the different conditions of liver disease and the different types of cell death, we provide different research directions and drug development services for specific situations.
- For cell death types such as cell necrosis and cell scorch death that promote the progression of liver disease, we screen and perform subsequent evaluation stages based on the inhibitory activity of the drug candidates and synthesize the effects of candidate modulators on different cell death types.
- For cell death types such as apoptosis and autophagy, we will screen according to the type and severity of liver disease to achieve targeted drug development studies.
- For diseases such as liver cancer, we will conduct extensive screening of compounds that effectively kill cancer cells, as well as develop efficient drug delivery systems that enable the targeted killing of cancer cells.
Ace Therapeutics has extensive research experience in the field of drug development for liver disease. Our scientists are adept at identifying each potential target and exploring it vigorously and deeply to develop more effective drugs for liver disease. If you have any comments or questions, please contact us so we can help you better.
Related Services
Our products and services are for research use only and can not be used for diagnostic or other purposes.
